Growth Factors of Compression Therapy Market
Compression therapy, a cornerstone in managing venous and lymphatic disorders, has witnessed significant advancements and market growth in recent years. As of 2018, the global compression therapy market was valued at USD 3.01 billion and is projected treach USD 4.51 billion by 2026, exhibiting a compound annual growth rate (CAGR) of 5.2% during the forecast period.
Understanding Compression Therapy
Compression therapy involves applying controlled pressure tthe lower extremities tenhance blood flow and support the lymphatic and venous systems. This method is pivotal in treating conditions such as venous leg ulcers, lymphedema, and deep vein thrombosis (DVT). The therapy primarily utilizes compression garments, including bandages and stockings, as well as devices like compression pumps.
Market Dynamics
Drivers:
1. Rising Prevalence of Venous and Lymphatic Disorders: An increase in conditions like venous leg ulcers and lymphedema has been observed globally. Factors such as immobility, obesity, and varicose veins contribute tthese disorders. For instance, venous leg ulceration affects approximately 1.5% of the general population and up t5% of the elderly.
2. Technological Advancements: Continuous research and development have led tinnovative compression products. Companies are introducing advanced compression garments and devices that offer improved efficacy and patient comfort. For example, in April 2022, Koya Medical launched an active compression system for lymphedema and venous diseases, featuring a soft, breathable mesh garment with proprietary Flexframe technology.
Restraints:
1. High Treatment Costs: Advanced compression therapies can be expensive, posing challenges for patients without adequate insurance coverage. For example, cancer-induced lymphedema treatment can cost over $62,000 in hospitalization expenses.
2. Lack of Awareness: In many low- and middle-income countries, there is limited awareness about venous and lymphatic disorders and their treatments, leading tunderdiagnosis and undertreatment.
Regional Insights
North America dominated the compression therapy market, holding a 34.77% share in 2018. This is attributed tthe high prevalence of lymphedema and venous diseases, coupled with advanced healthcare infrastructure. Europe follows closely, driven by increasing adoption of compression garments and supportive healthcare policies. The Asia-Pacific region is expected twitness significant growth due trising healthcare awareness and improving medical facilities.
Competitive Landscape
The market is characterized by strategic initiatives such as product launches, partnerships, and acquisitions. For instance, in February 2018, SIGVARIS expanded its product portfoliby introducing COOLFLEX™ NF, COMPREFLEX® REDUCE, and COMPREFLEX ARM, targeting venous diseases and lymphedema.
Key players in the market include:
- SIGVARIS
- Essity Aktiebolag (publ)
- Arjo
- PAUL HARTMANN Pty. Ltd
- 3M
- Tactile Systems Technology, Inc.
- Smith & Nephew
- medi GmbH & Co. KG
The compression therapy market is poised for steady growth, driven by the increasing prevalence of venous and lymphatic disorders and continuous product innovations. However, addressing challenges such as high treatment costs and lack of awareness is crucial. Efforts tdevelop cost-effective solutions and educational initiatives can further enhance market penetration and improve patient outcomes globally.
ATTRIBUTE DETAILS
Study Period - 2015-2026
Base Year - 2018
Forecast Period - 2019-2026
Historical Period - 2015-2017
Unit - Value (USD billion)
Segmentation By Product
- Compression Garments
- Compression Bandages
- Compression Stockings
- Others
- Compression Pumps
- Others
- Venous Leg Ulcer
- Deep Vein Thrombosis (DVT)
- Lymphedema
- Others
- Hospitals & Clinics
- Nursing Care Centers
- Home Care Settings
- Others
- North America (the U.S. and Canada)
- Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and the Rest of Europe)
- Asia-Pacific (Japan, China, India, Australia, Southeast Asia, and the Rest of Asia- Pacific)
- Latin America (Brazil, Mexico, and the Rest of Latin America)
- Middle East & Africa (South Africa, GCC and the Rest of Middle East &Africa)
Please Note: It will take 5-6 business days to complete the report upon order confirmation.
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 4. Key Insights
- 4.1. Prevalence of Venous Leg Ulcer, DVT, Lymphedema and other key indications by country/region
- 4.2. Key Industry Trends
- 4.3. Key Industry Developments (Mergers, Acquisitions, and Partnerships)
- 4.4. New Product Launches
- 5. Global Compression Therapy Market Analysis, Insights and Forecast, 2015-2026
- 5.1. Key Findings / Summary
- 5.2. Market Analysis, Insights and Forecast – By Product
- 5.2.1. Compression Garments
- 5.2.1.1. Compression Bandages
- 5.2.1.2. Compression Stockings
- 5.2.1.3. Others
- 5.2.2. Compression Pumps
- 5.2.3. Others
- 5.3. Market Analysis, Insights and Forecast – By Application
- 5.3.1. Venous Leg Ulcer
- 5.3.2. Deep Vein Thrombosis
- 5.3.3. Lymphedema
- 5.3.4. Others
- 5.4. Market Analysis, Insights and Forecast – By End User
- 5.4.1. Hospitals & Clinics
- 5.4.2. Nursing Care Centers
- 5.4.3. Home Care
- 5.4.4. Others
- 5.5. Market Analysis, Insights and Forecast – By Country
- 5.5.1. North America
- 5.5.2. Europe
- 5.5.3. Asia Pacific
- 5.5.4. Latin America
- 5.5.5. Middle East & Africa
- 6. North America Compression Therapy Market Analysis, Insights and Forecast, 2015-2026
- 6.1. Key Findings / Summary
- 6.2. Market Analysis – By Product
- 6.2.1. Compression Garments
- 6.2.1.1. Compression Bandages
- 6.2.1.2. Compression Stockings
- 6.2.1.3. Others
- 6.2.2. Compression Pumps
- 6.2.3. Others
- 6.3. Market Analysis – By Application
- 6.3.1. Venous Leg Ulcer
- 6.3.2. Deep Vein Thrombosis
- 6.3.3. Lymphedema
- 6.3.4. Others
- 6.4. Market Analysis – By End User
- 6.4.1. Hospitals & Clinics
- 6.4.2. Nursing Care Centers
- 6.4.3. Home Care
- 6.4.4. Others
- 6.5. Market Analysis – By Country
- 6.5.1. U.S.
- 6.5.2. Canada
- 7. Europe Compression Therapy Market Analysis, Insights and Forecast, 2015-2026
- 7.1. Key Findings / Summary
- 7.2. Market Analysis – By Product
- 7.2.1. Compression Garments
- 7.2.1.1. Compression Bandages
- 7.2.1.2. Compression Stockings
- 7.2.1.3. Others
- 7.2.2. Compression Pumps
- 7.2.3. Others
- 7.3. Market Analysis – By Application
- 7.3.1. Venous Leg Ulcer
- 7.3.2. Deep Vein Thrombosis
- 7.3.3. Lymphedema
- 7.3.4. Others
- 7.4. Market Analysis – By End User
- 7.4.1. Hospitals & Clinics
- 7.4.2. Nursing Care Centers
- 7.4.3. Home Care
- 7.4.4. Others
- 7.5. Market Analysis – By Country/Sub-region
- 7.5.1. U.K.
- 7.5.2. Germany
- 7.5.3. France
- 7.5.4. Spain
- 7.5.5. Italy
- 7.5.6. Scandinavia
- 7.5.7. Rest of Europe
- 8. Asia Pacific Compression Therapy Market Analysis, Insights and Forecast, 2015-2026
- 8.1. Key Findings / Summary
- 8.2. Market Analysis – By Product
- 8.2.1. Compression Garments
- 8.2.1.1. Compression Bandages
- 8.2.1.2. Compression Stockings
- 8.2.1.3. Others
- 8.2.2. Compression Pumps
- 8.2.3. Others
- 8.3. Market Analysis – By Application
- 8.3.1. Venous Leg Ulcer
- 8.3.2. Deep Vein Thrombosis
- 8.3.3. Lymphedema
- 8.3.4. Others
- 8.4. Market Analysis – By End User
- 8.4.1. Hospitals & Clinics
- 8.4.2. Nursing Care Centers
- 8.4.3. Home Care
- 8.4.4. Others
- 8.5. Market Analysis – By Country/Sub-region
- 8.5.1. Japan
- 8.5.2. China
- 8.5.3. India
- 8.5.4. Australia
- 8.5.5. Southeast Asia
- 8.5.6. Rest of Asia Pacific
- 9. Latin America Compression Therapy Market Analysis, Insights and Forecast, 2015-2026
- 9.1. Key Findings / Summary
- 9.2. Market Analysis – By Product
- 9.2.1. Compression Garments
- 9.2.1.1. Compression Bandages
- 9.2.1.2. Compression Stockings
- 9.2.1.3. Others
- 9.2.2. Compression Pumps
- 9.2.3. Others
- 9.3. Market Analysis – By Application
- 9.3.1. Venous Leg Ulcer
- 9.3.2. Deep Vein Thrombosis
- 9.3.3. Lymphedema
- 9.3.4. Others
- 9.4. Market Analysis – By End User
- 9.4.1. Hospitals & Clinics
- 9.4.2. Nursing Care Centers
- 9.4.3. Home Care
- 9.4.4. Others
- 9.5. Market Analysis – By Country
- 9.5.1. Brazil
- 9.5.2. Mexico
- 9.5.3. Rest of Latin America
- 10. Middle East & Africa Compression Therapy Market Analysis, Insights and Forecast, 2015-2026
- 10.1. Key Findings / Summary
- 10.2. Market Analysis – By Product
- 10.2.1. Compression Garments
- 10.2.1.1. Compression Bandages
- 10.2.1.2. Compression Stockings
- 10.2.1.3. Others
- 10.2.2. Compression Pumps
- 10.3. Others
- 10.4. Market Analysis – By Application
- 10.4.1. Venous Leg Ulcer
- 10.4.2. Deep Vein Thrombosis
- 10.4.3. Lymphedema
- 10.4.4. Others
- 10.5. Market Analysis – By End User
- 10.5.1. Hospitals & Clinics
- 10.5.2. Nursing Care Centers
- 10.5.3. Home Care
- 10.5.4. Others
- 10.6. Market Analysis – By Country/Sub-region
- 10.6.1. GCC Countries
- 10.6.2. South Africa
- 10.6.3. Rest of Middle East & Africa
- 11. Competitive Analysis
- 11.1. Key Industry Developments
- 11.2. Global Market Share Analysis (2018)
- 11.3. Competition Dashboard
- 11.4. Comparative Analysis – Major Players
- 11.5. Company Profiles (Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability))
- 11.5.1. SIGVARIS
- 11.5.1.1. Overview,
- 11.5.1.2. Products & services,
- 11.5.1.3. SWOT analysis,
- 11.5.1.4. Recent developments,
- 11.5.1.5. strategies,
- 11.5.1.6. financials (based on availability)
- 11.5.2. 3M
- 11.5.2.1. Overview,
- 11.5.2.2. Products & services,
- 11.5.2.3. SWOT analysis,
- 11.5.2.4. Recent developments,
- 11.5.2.5. strategies,
- 11.5.2.6. financials (based on availability)
- 11.5.3. Arjo
- 11.5.3.1. Overview,
- 11.5.3.2. Products & services,
- 11.5.3.3. SWOT analysis,
- 11.5.3.4. Recent developments,
- 11.5.3.5. strategies,
- 11.5.3.6. financials (based on availability)
- 11.5.4. PAUL HARTMANN Pty. Ltd
- 11.5.4.1. Overview,
- 11.5.4.2. Products & services,
- 11.5.4.3. SWOT analysis,
- 11.5.4.4. Recent developments,
- 11.5.4.5. strategies,
- 11.5.4.6. financials (based on availability)
- 11.5.5. medi GmbH & Co. KG
- 11.5.5.1. Overview,
- 11.5.5.2. Products & services,
- 11.5.5.3. SWOT analysis,
- 11.5.5.4. Recent developments,
- 11.5.5.5. strategies,
- 11.5.5.6. financials (based on availability)
- 11.5.6. Essity Aktiebolag (publ)
- 11.5.6.1. Overview,
- 11.5.6.2. Products & services,
- 11.5.6.3. SWOT analysis,
- 11.5.6.4. Recent developments,
- 11.5.6.5. strategies,
- 11.5.6.6. financials (based on availability)
- 11.5.7. Smith & Nephew
- 11.5.7.1. Overview,
- 11.5.7.2. Products & services,
- 11.5.7.3. SWOT analysis,
- 11.5.7.4. Recent developments,
- 11.5.7.5. strategies,
- 11.5.7.6. financials (based on availability)
- 11.5.8. Bio Compression Systems, Inc.
- 11.5.8.1. Overview,
- 11.5.8.2. Products & services,
- 11.5.8.3. SWOT analysis,
- 11.5.8.4. Recent developments,
- 11.5.8.5. strategies,
- 11.5.8.6. financials (based on availability)
- 11.5.9. Tactile Systems Technology, Inc.
- 11.5.9.1. Overview,
- 11.5.9.2. Products & services,
- 11.5.9.3. SWOT analysis,
- 11.5.9.4. Recent developments,
- 11.5.9.5. strategies,
- 11.5.9.6. financials (based on availability)
- 11.5.10. Other Players
- 11.5.10.1. Overview,
- 11.5.10.2. Products & services,
- 11.5.10.3. SWOT analysis,
- 11.5.10.4. Recent developments,
- 11.5.10.5. strategies,
- 11.5.10.6. financials (based on availability)
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook